Isotopia Molecular Imaging

Radioactive Isotopes for Nuclear Therapy

Health Tech & Life Sciences
Active
Mature Petah Tikva, Israel Founded 2007
Last updated 2026-06-18
Total raised
$3.8M
Last: 2007-07
Stage
Mature
Founded
2007
Headcount
109
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes diagnostic and therapeutic radioactive isotopes and advanced PET and SPECT radiotracers.

Its flagship product, the radioisotope Lutetium-177 (both C.A and N.C.A), has attracted considerable attention and exhibited great promise in treating a variety of late-stage cancers, including metastatic prostate cancer and neuroendocrine tumors.

Its production facilities include an advanced nuclear pharmacy that provides radionuclide labelled compounds for PET/SPECT imaging, a cyclotron facility, and an aseptic manufacturing plant that also offers contract manufacturing services (CMO).

Funding history · 1 round · $3.8M total

2007-07

Q&A

What is Isotopia Molecular Imaging's primary business?
Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes diagnostic and therapeutic radioactive isotopes and advanced PET and SPECT radiotracers.
What is Isotopia Molecular Imaging's flagship product?
Isotopia Molecular Imaging's flagship product is the radioisotope Lutetium-177 (both C.A and N.C.A), which is used in treating various late-stage cancers, including metastatic prostate cancer and neuroendocrine tumors.
When was Isotopia Molecular Imaging founded?
Isotopia Molecular Imaging was founded in February 2007.
How much funding has Isotopia Molecular Imaging raised in total?
Isotopia Molecular Imaging has raised a total of $3,750,000.
When was Isotopia Molecular Imaging's last funding round and who were the lead investors?
Isotopia Molecular Imaging's last funding round was in July 2007, with Metrontario as the lead investor.
How many employees does Isotopia Molecular Imaging have?
Isotopia Molecular Imaging has 51-200 employees.
Where is Isotopia Molecular Imaging's headquarters located?
Isotopia Molecular Imaging's headquarters is located in Petah Tikva, Israel.
Who is the Co-founder and CEO of Isotopia Molecular Imaging?
Dr. Eli Shalom is the Co-founder and CEO of Isotopia Molecular Imaging.

Team · 1

Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Simulation & ImagingBiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareLife SciencesPharmaceuticalsMedical Devices IndustryMedical Equipment
Business model
B2B

Highlights

1 PatentsVerified

Tags

precision-medicinecancer-therapycancertargeted-cancer-therapyradiologyscanningradiopharmaceuticalshospitalspharma-companiesdoctorshealthcare-providerscancer-diagnosticscancer-researchpharmaceuticalsclinical-trialsbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)